Pilar Mur Molina
Pilar Mur Molina
Catalan Institute of Oncology, IDIBELL
Verified email at iconcologia.net
Cited by
Cited by
MLH1 promoter hypermethylation in the analytical algorithm of Lynch syndrome: a cost-effectiveness study
M Gausachs, P Mur, J Corral, M Pineda, S González, L Benito, ...
European journal of human genetics 20 (7), 762-768, 2012
Codeletion of 1p and 19q determines distinct gene methylation and expression profiles in IDH-mutated oligodendroglial tumors
P Mur, M Mollejo, Y Ruano, ÁR de Lope, C Fiaño, JF García, ...
Acta neuropathologica 126 (2), 277-289, 2013
Genetic alterations associated with progression and recurrence in meningiomas
E Pérez-Magán, Y Campos-Martín, P Mur, C Fiaño, T Ribalta, JF García, ...
Journal of Neuropathology & Experimental Neurology 71 (10), 882-893, 2012
MLH1 methylation screening is effective in identifying epimutation carriers
M Pineda, P Mur, MD Iniesta, E Borràs, O Campos, G Vargas, S Iglesias, ...
European journal of human genetics 20 (12), 1256-1264, 2012
Impact on prognosis of the regional distribution of MGMT methylation with respect to the CpG island methylator phenotype and age in glioma patients
P Mur, ÁR De Lope, FJ Díaz-Crespo, T Hernández-Iglesias, T Ribalta, ...
Journal of neuro-oncology 122 (3), 441-450, 2015
Molecular classification defines 4 prognostically distinct glioma groups irrespective of diagnosis and grade
P Mur, M Mollejo, T Hernández-Iglesias, ÁR de Lope, JS Castresana, ...
Journal of Neuropathology & Experimental Neurology 74 (3), 241-249, 2015
Delineating the phenotypic spectrum of the NTHL1-associated polyposis
S Belhadj, P Mur, M Navarro, S González, V Moreno, G Capellá, L Valle
Clinical Gastroenterology and Hepatology 15 (3), 461-462, 2017
Gene expression changes associated with erlotinib response in glioma cell lines
A García-Claver, M Lorente, P Mur, Y Campos-Martín, M Mollejo, ...
European Journal of Cancer 49 (7), 1641-1653, 2013
Association between germline mutations in BRF1, a subunit of the RNA polymerase III transcription complex, and hereditary colorectal cancer
F Bellido, N Sowada, P Mur, C Lázaro, T Pons, R Valdés-Mas, M Pineda, ...
Gastroenterology 154 (1), 181-194. e20, 2018
Evidence suggests that germline RNF43 mutations are a rare cause of serrated polyposis
I Quintana, R Mejías-Luque, M Terradas, M Navarro, V Piñol, P Mur, ...
Gut 67 (12), 2230-2232, 2018
Plasma viral miRNAs indicate a high prevalence of occult viral infections
E Fuentes-Mattei, DE Giza, M Shimizu, C Ivan, JT Manning, S Tudor, ...
EBioMedicine 20, 182-192, 2017
Identification of a founder EPCAM deletion in Spanish Lynch syndrome families
P Mur, M Pineda, A Romero, J Del Valle, E Borras, A Canal, M Navarro, ...
Clinical Genetics 85 (3), 260-266, 2014
Germline variation in O6-methylguanine-DNA methyltransferase (MGMT) as cause of hereditary colorectal cancer
S Belhadj, C Moutinho, P Mur, F Setien, P Llinàs-Arias, M Pérez-Salvia, ...
Cancer letters 447, 86-92, 2019
Germline mutations in the spindle assembly checkpoint genes BUB1 and BUB3 are infrequent in familial colorectal cancer and polyposis
P Mur, RM De Voer, R Olivera-Salguero, S Rodríguez-Perales, T Pons, ...
Molecular cancer 17 (1), 1-6, 2018
Copy number alterations in glioma cell lines
B Meléndez, A García-Claver, Y Ruano, Y Campos-Martín, AR de Lope, ...
Glioma-Exploring Its Biology and Practical Relevance, 2011
Scarce evidence of the causal role of germline mutations in UNC5C in hereditary colorectal cancer and polyposis
P Mur, E Sánchez-Cuartielles, S Aussó, G Aiza, R Valdés-Mas, M Pineda, ...
Scientific reports 6 (1), 1-8, 2016
Germline variation in the oxidative DNA repair genes NUDT1 and OGG1 is not associated with hereditary colorectal cancer or polyposis
P Mur, AS Jemth, L Bevc, N Amaral, M Navarro, R Valdés‐Mas, T Pons, ...
Human mutation 39 (9), 1214-1225, 2018
NTHL1 biallelic mutations seldom cause colorectal cancer, serrated polyposis or a multi-tumor phenotype, in absence of colorectal adenomas
S Belhadj, I Quintana, P Mur, PM Munoz-Torres, MH Alonso, M Navarro, ...
Scientific reports 9 (1), 1-5, 2019
miR-543 regulates the epigenetic landscape of myelofibrosis by targeting TET1 and TET2
E Fuentes-Mattei, R Bayraktar, T Manshouri, AM Silva, C Ivan, D Gulei, ...
JCI insight 5 (1), 2020
Approaches to functionally validate candidate genetic variants involved in colorectal cancer predisposition
L Bonjoch, P Mur, C Arnau-Collell, G Vargas-Parra, B Shamloo, ...
Molecular aspects of medicine 69, 27-40, 2019
The system can't perform the operation now. Try again later.
Articles 1–20